SCHEMBL3543064

SCHEMBL3543064

CCCS(=O)(=O)NC(c1ccc(OC(F)(F)F)cc1)C1CCN(Cc2ccc(-c3nnn(C)n3)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.39
CHRM2 P08172 2/20 0.38
CHRM1 P11229 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
JAK3 P52333 1/20 0.38
CCR5 P51681 1/20 0.38
ACHE P22303 3/20 0.38
BCHE P06276 2/20 0.38
BACE1 P56817 2/20 0.38
MMP2 P08253 2/20 0.37
MMP3 P08254 2/20 0.37
MMP9 P14780 2/20 0.37
MMP8 P22894 2/20 0.37
MMP13 P45452 2/20 0.37
MMP7 P09237 1/20 0.37
TEAD1 P28347 2/20 0.36
MGAT2 Q10469 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3543063 0.81 ALDH1A1 (0.41) ALDH1A1TSHRCHRM2CHRM1JAK2
SCHEMBL7466544 0.74 ALDH1A1 (0.49) ALDH1A1TSHRCHRM2CHRM1CCR5
SCHEMBL3544201 0.74 TSHR (0.49) ALDH1A1TSHRCHRM2CHRM1JAK2
SCHEMBL3544658 0.74 ALDH1A1 (0.40) ALDH1A1TSHRCHRM2CHRM1JAK2
SCHEMBL13846113 0.69 NPC1 (0.52) ALDH1A1ACHEBCHESCN5A
SCHEMBL645530 0.69 ALDH1A1 (0.48) ALDH1A1TSHRCHRM2CHRM1MMP2
SCHEMBL3539735 0.67 HTR2A (0.45) ALDH1A1TSHRCHRM2TEAD1HTR2A
SCHEMBL5102977 0.67 CHRM2 (0.47) ALDH1A1TSHRCHRM2CHRM1ACHE
SCHEMBL3747476 0.66 CYP11B2 (0.49)
SCHEMBL646076 0.65 CCR5 (0.50) ALDH1A1TSHRCCR5DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683070-B2 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines FMC CORPORATION (US) 2010-03-23 US disclosed
US-20080090828-A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines BAYER CROPSCIENCE AG (DE) 2008-04-17 US disclosed
US-7300946-B2 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines BAYER CROPSCIENCE AG (DE) 2007-11-27 US disclosed
EP-1572207-A4 N-(SUBSTITUTED ARYLMETHYL)-4-(DISUBSTITUTED METHYL) PIPERIDINES AND PYRIDINES FMC CORP (US) 2006-11-29 EP disclosed
US-20060135504-A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines FMC CORPORATION 2006-06-22 US disclosed
EP-1572207-A1 N-(SUBSTITUTED ARYLMETHYL)-4-(DISUBSTITUTED METHYL) PIPERIDINES AND PYRIDINES FMC CORPORATION (US) 2005-09-14 EP disclosed
WO-2004060371-A1 N-(SUBSTITUTED ARYLMETHYL)-4-(DISUBSTITUTED METHYL) PIPERIDINES AND PYRIDINES FMC CORPORATION (US) 2004-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135504-A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines DDT, DRD4, QDPR ALDH1A1 1706/4885TSHR 1422/4885CHRM2 15/4885
US-20080090828-A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines DDT, DRD4, QDPR ALDH1A1 1757/4885TSHR 1186/4885CHRM2 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.